Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma
Clinical trial NCT07225985 · RECRUITING
Trial details
- NCT number
- NCT07225985
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-27
- Primary completion
- 2030-09-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.